Benitec Biopharma Inc.
BNTC· Nasdaq
BNTCBenitec Biopharma Inc.
Filed Feb 14, 2022 · 10-Q · 45 days after period end · 0001193125-22-039683
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $25.00K | $1.00K | $77.00K |
| Net Income | -$4.82M | -$3.25M | -$2.09M |
| EPS Diluted | -$0.59 | -$0.76 | -$2.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 14, 2022 · 45 d after period end
